Recombinant Human STK38 protein is a Human Full Length protein, in the 2 to 465 aa range, expressed in Baculovirus, with >80% purity and suitable for SDS-PAGE, WB.
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application WB | Reactivity Reacts | Dilution info - | Notes - |
Select an associated product type
Serine/threonine-protein kinase that acts as a negative regulator of MAP3K1/2 signaling (PubMed:12493777, PubMed:15197186, PubMed:17906693, PubMed:7761441). Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2 (PubMed:12493777, PubMed:15197186, PubMed:17906693, PubMed:7761441). Acts as an ufmylation 'reader' in a kinase-independent manner: specifically recognizes and binds mono-ufmylated histone H4 in response to DNA damage, promoting the recruitment of SUV39H1 to the double-strand breaks, resulting in ATM activation (PubMed:32537488).
NDR1, STK38, Serine/threonine-protein kinase 38, NDR1 protein kinase, Nuclear Dbf2-related kinase 1
Recombinant Human STK38 protein is a Human Full Length protein, in the 2 to 465 aa range, expressed in Baculovirus, with >80% purity and suitable for SDS-PAGE, WB.
pH: 7.5
Constituents: 25% Glycerol (glycerin, glycerine), 0.87% Sodium chloride, 0.79% Tris HCl, 0.307% Glutathione, 0.00385% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.00292% EDTA, 0.00174% PMSF
The purity was determined to be >80% by densitometry. Affinity purified.
Serine/threonine-protein kinase that acts as a negative regulator of MAP3K1/2 signaling (PubMed:12493777, PubMed:15197186, PubMed:17906693, PubMed:7761441). Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2 (PubMed:12493777, PubMed:15197186, PubMed:17906693, PubMed:7761441). Acts as an ufmylation 'reader' in a kinase-independent manner: specifically recognizes and binds mono-ufmylated histone H4 in response to DNA damage, promoting the recruitment of SUV39H1 to the double-strand breaks, resulting in ATM activation (PubMed:32537488).
Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family.
ISGylated.
STK38 also known as NDR1 (nuclear Dbf2-related kinase 1) is a serine/threonine kinase with a molecular mass of approximately 54 kDa. It plays an important role in the regulation of cell proliferation and apoptosis through its involvement in phosphorylation processes. This protein is expressed in various tissues including the brain heart and muscle indicating its broad functional roles across different biological systems. Through its kinase activity STK38 modulates several intracellular pathways critical for maintaining cellular functions.
STK38 is essential for regulating apoptosis and cell cycle progression. It acts as part of a larger signaling complex engaging in interactions with different proteins to exert its effects. Phosphorylation by STK38 often leads to activation or inhibition of downstream targets influencing cell survival and division. It can interact with MOB1 and LATS1/2 which highlights its role in the Hippo signaling pathway important for controlling organ size and suppressing tumors.
The STK38 protein integrates itself into the Hippo and mTOR pathways. In the Hippo pathway its interactions with MOB1 and LATS proteins are important for regulating organ size and maintaining balance between cell growth and death. In the mTOR pathway STK38 influences metabolic processes and cell growth by modifying signal transduction that is critical for cellular homeostasis. These pathways are vital for normal cellular function and highlight the regulatory versatility of STK38.
STK38 plays a significant role in cancer and neurodegenerative diseases. Aberrant activity or expression levels of STK38 can contribute to the development of certain cancers due to dysregulated cell proliferation and survival. In neurodegenerative diseases improper functioning of STK38 can lead to loss of neuronal cell integrity and increased cell death. Through its interactions with cancer-related proteins such as YAP1 and neurologically relevant proteins alterations in STK38 signaling may exacerbate disease progression.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
SDS-PAGE analysis of ab101505.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com